Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices

Global Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices Market to Reach US$35.4 Billion by 2030

The global market for Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices estimated at US$24.2 Billion in the year 2024, is expected to reach US$35.4 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Asthma Application, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$11.9 Billion by the end of the analysis period. Growth in the COPD Application segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.6 Billion While China is Forecast to Grow at 10.0% CAGR

The Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices market in the U.S. is estimated at US$6.6 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.2 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Market for Incubators, Inhalators, Respirators, Resuscitators, and Other Breathing Devices – Key Trends & Drivers Summarized

How Are Life-Sustaining Respiratory Devices Becoming the Backbone of Critical Care?

The role of respiratory support devices such as incubators, inhalators, respirators, resuscitators, and related breathing systems has grown exponentially in both clinical and emergency care environments. These technologies are no longer seen as mere support tools but as foundational equipment for sustaining life across a wide range of patient demographics and conditions. In neonatal intensive care units, incubators have become essential for ensuring thermal regulation and infection control for premature or low-birth-weight infants. Inhalators, used for delivering bronchodilators and corticosteroids, are increasingly relied upon for the treatment of asthma, COPD, and allergic reactions. Respirators and mechanical ventilators have taken center stage in managing acute respiratory distress, especially during pandemics or post-surgical recovery, where autonomous breathing is impaired. Resuscitators, often used in ambulances and emergency rooms, are crucial for restoring normal respiratory function during cardiac or respiratory arrest. These devices are indispensable in both chronic disease management and acute interventions, highlighting their multifaceted application across inpatient, outpatient, and home care settings. The global rise in respiratory illnesses, aging populations, and urban pollution has made breathing assistance devices a constant presence in modern medicine. Their relevance is further underscored during public health emergencies, where the scalability and reliability of such equipment can mean the difference between life and death. In every setting from hospitals to disaster relief zones, these devices form the respiratory core of patient survival and recovery.

What Technological Innovations Are Enhancing Efficiency and Patient Outcomes?

Cutting-edge innovation is redefining the landscape of breathing support devices, pushing the boundaries of safety, portability, and clinical effectiveness. One of the most notable advancements has been the integration of smart monitoring systems within incubators and respirators, allowing caregivers to track vital signs in real time and make data-driven decisions without invasive intervention. For example, modern incubators are equipped with microclimate control, touchless monitoring, and humidity regulation features that ensure the safest environment for neonates. Inhalators have evolved to include digital dose counters, Bluetooth-enabled adherence trackers, and even voice-guided usage instructions, helping patients with chronic respiratory diseases manage their treatments more effectively. Respirators now come with adaptive algorithms that automatically adjust ventilation settings based on patient feedback, minimizing complications and reducing the burden on healthcare staff. Battery-operated, lightweight resuscitators with advanced pressure control features are improving emergency response efficiency in remote and transport settings. Many of these devices now feature touchscreen interfaces and cloud-connected data portals that link patient outcomes to centralized electronic health records. Manufacturers are also using antimicrobial materials, advanced HEPA filtration, and noise-reduction technology to improve hygiene and patient comfort. With the rise of telemedicine and home healthcare, demand for compact and user-friendly respiratory devices is increasing, prompting innovation in ergonomic design and mobile compatibility. These technological strides are not only improving therapeutic outcomes but are also enhancing user experience, ensuring that both patients and providers benefit from a seamless and safe care journey.

How Are Public Health Needs and Clinical Demands Driving Device Adoption?

The growing burden of respiratory diseases, coupled with changing healthcare delivery models, is significantly shaping the demand for advanced breathing support devices. Chronic respiratory illnesses such as asthma, chronic bronchitis, and pulmonary fibrosis are becoming more prevalent, especially in aging populations and regions affected by industrial pollution and tobacco use. This surge in cases has created a pressing need for accessible, effective, and user-friendly treatment devices. Incubators are in high demand in countries facing high infant mortality rates or where preterm births are on the rise due to maternal health complications. Inhalators are becoming household devices as doctors increasingly prescribe long-term inhalation therapy for chronic patients. Respirators and ventilators, once confined to intensive care units, are now being deployed in ambulatory settings and even homes, particularly for patients with progressive neuromuscular diseases. Public health emergencies such as the COVID-19 pandemic exposed critical gaps in respiratory infrastructure, prompting governments and healthcare institutions to increase investment in stockpiling and upgrading such devices. Emergency services and disaster preparedness teams are also prioritizing portable resuscitation kits and field-ready respiratory systems to enhance response capabilities. Insurance providers and policymakers are recognizing the value of early respiratory intervention, offering greater reimbursement and access to patients. Additionally, global health initiatives and non-profit organizations are working to provide breathing devices to underserved regions, amplifying awareness and demand. These wide-ranging clinical and public health needs are accelerating the adoption and continuous innovation of breathing support technologies across both developed and emerging markets.

What Factors Are Fueling the Global Expansion of the Respiratory Devices Market?

The global market for incubators, inhalators, respirators, resuscitators, and other respiratory devices is expanding rapidly due to a mix of demographic, economic, and technological influences. A key driver is the aging global population, which is inherently more susceptible to respiratory complications and requires long-term breathing assistance. Urbanization and industrialization, particularly in Asia-Pacific and parts of Africa, are contributing to environmental conditions that lead to higher incidences of asthma, lung infections, and air pollution-related health problems. Increased healthcare spending in both private and public sectors is enabling hospitals and clinics to upgrade outdated equipment and adopt newer, more efficient systems. Another powerful force behind this growth is the rising focus on home healthcare, where patients with chronic conditions prefer to manage their health in familiar environments using compact, portable breathing devices. The surge in remote monitoring technologies and wearable medical devices is supporting this trend by providing real-time oversight and reducing the need for hospital readmissions. Additionally, awareness campaigns by health organizations are educating the public about the importance of respiratory health, leading to early diagnosis and treatment using these devices. Government funding, healthcare reforms, and favorable reimbursement policies in several countries are further making these devices accessible to larger sections of the population. Manufacturers are also forming strategic partnerships with hospitals, pharmacies, and e-commerce platforms to broaden distribution and enhance last-mile delivery. The combination of these factors is creating a robust ecosystem that supports sustained growth in the breathing device market, positioning it as a cornerstone of modern healthcare delivery worldwide.

SCOPE OF STUDY:

The report analyzes the Incubators, Inhalators, Respirators, Resuscitators and Other Breathing Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Application (Asthma Application, COPD Application, Obstructive Sleep Apnea Application, Other Applications); End-Use (Healthcare Settings End-Use, Pharmaceuticals Companies End-Use)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Ambu A/S
• BD (Becton, Dickinson & Co.)
• Bio-Med Devices, Inc.
• Drägerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare
• GE HealthCare
• Getinge AB
• Hamilton Medical AG
• HEYER Medical AG
• Hill-Rom Holdings, Inc. (Baxter)
• Inspiration Healthcare Group
• Koninklijke Philips N.V.
• Löwenstein Medical GmbH & Co. KG
• Medtronic plc
• Mindray Medical International
• Nihon Kohden Corporation
• PARI GmbH
• ResMed Inc.
• Smiths Medical (ICU Medical)
• Vyaire Medical, Inc.

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.